CA1190148A - Composes contenant de l'interferon - Google Patents

Composes contenant de l'interferon

Info

Publication number
CA1190148A
CA1190148A CA000413238A CA413238A CA1190148A CA 1190148 A CA1190148 A CA 1190148A CA 000413238 A CA000413238 A CA 000413238A CA 413238 A CA413238 A CA 413238A CA 1190148 A CA1190148 A CA 1190148A
Authority
CA
Canada
Prior art keywords
composition
surface active
active agent
interferon
amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000413238A
Other languages
English (en)
Inventor
Samuel S. Asculai
Fred Rapp
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
VG Life Sciences Inc
Original Assignee
VG Life Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by VG Life Sciences Inc filed Critical VG Life Sciences Inc
Application granted granted Critical
Publication of CA1190148A publication Critical patent/CA1190148A/fr
Expired legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA000413238A 1981-10-13 1982-10-12 Composes contenant de l'interferon Expired CA1190148A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31103581A 1981-10-13 1981-10-13
US311,035 1981-10-13

Publications (1)

Publication Number Publication Date
CA1190148A true CA1190148A (fr) 1985-07-09

Family

ID=23205109

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000413238A Expired CA1190148A (fr) 1981-10-13 1982-10-12 Composes contenant de l'interferon

Country Status (2)

Country Link
JP (1) JPS5877824A (fr)
CA (1) CA1190148A (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP132A (en) * 1990-02-01 1991-05-19 Kenya Medical Res Institute Improved formulation of low-dose interferon alpha.

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0080032A3 (fr) * 1981-11-20 1985-11-13 Enzo Biochem, Inc. Préparation pharmaceutique pour le traitement de lésions herpétiques
DE3436638C2 (de) * 1984-10-05 1992-10-08 Bioferon biochemische Substanzen GmbH & Co, 7958 Laupheim Verwendung von Interferon-gamma (IFN-gamma) enthaltenden Präparationen zur Behandlung rheumatischer Erkrankungen
JPS61277633A (ja) * 1985-05-31 1986-12-08 Toray Ind Inc インタ−フエロン組成物
JPS62185030A (ja) * 1986-02-07 1987-08-13 Toray Ind Inc 経鼻投与用インタ−フエロン製剤
CA1294215C (fr) * 1986-10-27 1992-01-14 Ze'ev Shaked Compositions pharmaceutiques d'interferon beta recombinant et methodes de formulation
CA1321347C (fr) * 1986-11-10 1993-08-17 David C. Munch Composition d'interferon humain leucocytaire et traitement de la peau
DE3731255A1 (de) * 1987-09-17 1989-04-06 Boehringer Ingelheim Int Stabilisierung von therapeutisch wirksamen proteinen in pharmazeutischen zubereitungen
JPH0285443U (fr) * 1988-12-22 1990-07-04

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4184917A (en) * 1974-04-01 1980-01-22 Sandoz Ltd. Process for producing a structurally modified interferon
US4020183A (en) * 1974-12-03 1977-04-26 Ortho Pharmaceutical Corporation Nonionic surface active anti-herpes simplex viral agents
JPS5283936A (en) * 1976-01-01 1977-07-13 Ortho Pharma Corp Single herpes virus inactivating acent
JPS5562024A (en) * 1978-10-31 1980-05-10 Hayashibara Takeshi Preventive and remedy for interferon-sensitive disease
ZA796175B (en) * 1978-11-24 1980-11-26 Hoffmann La Roche Purified proteins and process therefor
JPS55102519A (en) * 1979-01-31 1980-08-05 Green Cross Corp:The Stabilization of interferon
MW2880A1 (en) * 1979-07-31 1981-12-09 Hoffmann La Roche Homogeneous fibroblast interferon and method for manufacture thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP132A (en) * 1990-02-01 1991-05-19 Kenya Medical Res Institute Improved formulation of low-dose interferon alpha.

Also Published As

Publication number Publication date
JPS6365050B2 (fr) 1988-12-14
JPS5877824A (ja) 1983-05-11

Similar Documents

Publication Publication Date Title
EP0077063B1 (fr) Compositions contenant de l'interféron et application de ces compositions dans le traitement des infections herpétiques, lésions prémalignes de la peau, malignités de la peau et psoriasis
US4507281A (en) Interferon-containing compositions
US4285934A (en) Treatment for herpes virus
US4309989A (en) Topical application of medication by ultrasound with coupling agent
US4381296A (en) Treatment for herpes virus
US4822605A (en) Compositions and methods employing the same for the treatment of viral and cancerous skin lesions and the like
US20030072814A1 (en) Topical pharmaceutical composition for the treatment of warts
GB1577551A (en) Medication for topical application by ultrasound
AU2002312416A1 (en) Compositions and methods for the prophylaxis and treatment of aphthous ulcers and herpes simplex lesions
US4957734A (en) Treatment of certain skin malignancies and pre-malignant skin lesions, herpes zoster and psoriasis
CA1190148A (fr) Composes contenant de l'interferon
BAKER et al. Topical podofilox for the treatment of condylomata acuminata in women
US4049798A (en) Method for the treatment of Herpes Simplex
US5182104A (en) Topical virucidal composition for treatment of mucocutaneous tissue
US4427684A (en) Treatment and prevention of infection with herpes simplex and related viruses
EP0502048B1 (fr) Utilisation de la cafeine dans le traitement des infections relatives a l'herpes "bouton de fievre"
Lozada-Nur et al. Retrospective findings of the clinical benefits of podophyllum resin 25% sol on hairy leukoplakia: Clinical results in nine patients
Rudy Imiquimod (Aldara): modifying the immune response
JPS58103324A (ja) インタ−フエロン組成物及びヘルペス感染症の治療における該組成物の使用
EP0105448B1 (fr) Utilisation de l'acide undécylénique pour la préparation d'une composition pour le traitement de l'Herpès labialis
US20040101571A1 (en) Use of hydrogen peroxide for the treatment of warts
Nelson et al. Clinical aspects of cutaneous leishmaniasis acquired in Texas
US5977176A (en) Compositions for the treatment of warts and herpes
WO1998017288A1 (fr) Medicament renfermant du lithium pour combattre les infections dues au virus du papillome humain
Nikkels et al. Current treatments of muco-cutaneous herpes simplex virus infections

Legal Events

Date Code Title Description
MKEC Expiry (correction)
MKEX Expiry